Literature DB >> 23318295

Alzheimer disease: Arrestin' Alzheimer disease progression? β-arrestin 2 is a potential therapeutic target.

Heather Wood.   

Abstract

Entities:  

Year:  2013        PMID: 23318295     DOI: 10.1038/nrneurol.2012.278

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  2 in total

1.  The orphan G protein-coupled receptor 3 modulates amyloid-beta peptide generation in neurons.

Authors:  Amantha Thathiah; Kurt Spittaels; Marcel Hoffmann; Mik Staes; Adrian Cohen; Katrién Horré; Mieke Vanbrabant; Frea Coun; Veerle Baekelandt; André Delacourte; David F Fischer; Dirk Pollet; Bart De Strooper; Pascal Merchiers
Journal:  Science       Date:  2009-02-13       Impact factor: 47.728

2.  β-arrestin 2 regulates Aβ generation and γ-secretase activity in Alzheimer's disease.

Authors:  Amantha Thathiah; Katrien Horré; An Snellinx; Elke Vandewyer; Yunhong Huang; Marta Ciesielska; Gerdien De Kloe; Sebastian Munck; Bart De Strooper
Journal:  Nat Med       Date:  2012-12-02       Impact factor: 53.440

  2 in total
  3 in total

Review 1.  β-Arrestins as potential therapeutic targets for Alzheimer's disease.

Authors:  Teng Jiang; Jin-Tai Yu; Meng-Shan Tan; Xi-Chen Zhu; Lan Tan
Journal:  Mol Neurobiol       Date:  2013-05-16       Impact factor: 5.590

2.  Prediction of miRNA-mRNA associations in Alzheimer's disease mice using network topology.

Authors:  Haneul Noh; Charny Park; Soojun Park; Young Seek Lee; Soo Young Cho; Hyemyung Seo
Journal:  BMC Genomics       Date:  2014-08-03       Impact factor: 3.969

3.  COX-1/PGE2/EP4 alleviates mucosal injury by upregulating β-arr1-mediated Akt signaling in colitis.

Authors:  Xiaojie Peng; Jianzhong Li; Siwei Tan; Minyi Xu; Jin Tao; Jie Jiang; Huiling Liu; Bin Wu
Journal:  Sci Rep       Date:  2017-04-21       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.